CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $453,000 | -40.4% | 71,200 | -2.3% | 0.01% | -25.0% |
| Q4 2019 | $760,000 | -3.1% | 72,900 | +322.6% | 0.01% | -82.1% |
| Q2 2018 | $784,000 | -16.3% | 17,250 | -2.8% | 0.07% | -28.0% |
| Q1 2018 | $937,000 | -23.4% | 17,750 | -1.4% | 0.09% | -27.3% |
| Q4 2017 | $1,224,000 | -19.7% | 18,000 | -2.7% | 0.13% | -19.5% |
| Q3 2017 | $1,524,000 | -12.0% | 18,500 | 0.0% | 0.16% | -22.4% |
| Q2 2017 | $1,732,000 | +47.0% | 18,500 | 0.0% | 0.20% | +30.6% |
| Q1 2017 | $1,178,000 | +32.7% | 18,500 | -7.5% | 0.16% | -13.7% |
| Q4 2016 | $888,000 | -42.7% | 20,000 | -53.5% | 0.18% | -35.0% |
| Q3 2016 | $1,550,000 | +53.8% | 43,000 | -18.1% | 0.28% | +53.0% |
| Q1 2016 | $1,008,000 | – | 52,500 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |